WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2005067919) 11-CSUBSITUTED ERYTHROMYCIN DERIVATIVES
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2005/067919    International Application No.:    PCT/US2003/041248
Publication Date: 28.07.2005 International Filing Date: 24.12.2003
IPC:
A61K 31/365 (2006.01), A61K 31/70 (2006.01), A61K 31/7048 (2006.01), C07D 313/00 (2006.01), C07D 313/06 (2006.01), C07D 313/20 (2006.01), C07H 17/08 (2006.01)
Applicants: ENANTA PHARMACEUTICALS, INC. [US/US]; 500 Arsenal Street, Watertown, MA 02472 (US)
Inventors: PHAN, Ly, Tam; (US).
OR, Yat, Sun; (US).
FARMER, Jay, Judson; (US)
Agent: FERRONE, Jason, D.; Enanta Pharmaceuticals, Inc., Attn.: Patent Dept., 500 Arsenal Street, Watertown, MA 02472 (US)
Priority Data:
Title (EN) 11-CSUBSITUTED ERYTHROMYCIN DERIVATIVES
(FR) DERIVES D'ERYTHROMYCINE 11-C SUBSTITUES
Abstract: front page image
(EN)The present invention discloses compounds of formulae I, II, III or IV or pharmaceutically acceptable salts, esters, or prodrugs thereof: (I), (II), (III), (IV), which exhibit antibacterial properties. The present invention further relates to pharmaceutical compositions comprising the aforementioned compounds for administration to a subject in need of antibiotic treatment. The invention also relates to methods of treating a bacterial infection in a subject by administering a pharmaceutical composition comprising the compounds of the present invention. The invention further includes process by which to make the compounds of the present invention.
(FR)L'invention concerne des composés de formule (I), (II), (III) ou (IV), ou des sels pharmaceutiquement acceptables, des esters ou des promédicaments desdits composés, présentant des propriétés antibactériennes. L'invention concerne en outre des compositions pharmaceutiques comprenant lesdits composés, destinées à être administrées à un sujet nécessitant un traitement antibiotique. L'invention concerne également des méthodes pour traiter une infection bactérienne chez un sujet en administrant une composition pharmaceutique comprenant lesdits composés. L'invention concerne également un procédé de production desdits composés.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MA, MD, MG, MK, MN, MW, MX, MZ, NO, NZ, OM, PH, PL, PT, RO, RU, SC, SD, SE, SG, SK, SL, TJ, TM, TN, TR, TT, TZ, UA, UG, UZ, VC, VN, YU, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LS, MW, MZ, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IT, LU, MC, NL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)